Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Chu v. BioAmber Inc. et al
Case Number:
2:17-cv-01531
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
-
June 06, 2017
Rosen, Goldberg Win Lead Roles In BioAmber Investor Suit
A New York federal judge on Tuesday appointed the Rosen Law Firm PA and Goldberg Law PC as co-lead counsel in an investor suit accusing sustainable chemicals company BioAmber Inc. of failing to disclose that its expected $2.8 million sale of succinic acid got postponed.
-
March 21, 2017
Investors Say Chemical Co. Didn't Disclose $2.8M Sale Delay
Sustainable chemicals company BioAmber Inc. didn't tell investors that its expected $2.8 million sale of succinic acid got postponed to 2017, despite touting increased revenue projections during its secondary public offering in January, a putative proposed class of shareholders have alleged in New York federal court.